MBrace Therapeutics

MBrace Therapeutics

Biotechnology Research

San Diego, California 1,695 followers

We are developing first in class ADC's directed to novel targets to improve the lives of patients with cancer.

About us

MBrace Therapeutics is a privately-held biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets. MBrace is supported by a world-class investor syndicate, including TPG, Avidity Partners, Cowen Healthcare Investments, Venrock and Alta Partners.

Website
www.mbracetrx.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
San Diego, California
Type
Privately Held
Founded
2020

Locations

  • Primary

    4660 La Jolla Village Dr

    950

    San Diego, California 92122, US

    Get directions

Employees at MBrace Therapeutics

Updates

Similar pages

Funding

MBrace Therapeutics 2 total rounds

Last Round

Series B

US$ 85.0M

See more info on crunchbase